Fig. 1From: Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter studyPrevalence of QT drug-drug interactions (QT-DDIs) stratified with respect to gender, age, diagnosis and types of malignancyBack to article page